Core Viewpoint - Samsung Medical's stock price increased by 4.56% to 23.61 yuan, with a rolling PE ratio of 13.91, marking a new low in 55 days, and a total market capitalization of 33.178 billion yuan [1][2] Company Summary - Samsung Medical's main business segments include smart power distribution and medical services, with key products such as smart meters, high-end gateway meters, smart terminals, power boxes, communication modules, and various integrated solutions [1] - The company has received multiple accolades, including being recognized as a national-level intellectual property demonstration enterprise and a provincial key enterprise research institute [1] Financial Performance - For the first quarter of 2025, Samsung Medical reported revenue of 3.631 billion yuan, a year-on-year increase of 20.03%, and a net profit of 489 million yuan, reflecting a year-on-year growth of 34.33% [2] - The company's gross profit margin stands at 28.90% [2] Industry Comparison - In the electric grid equipment industry, Samsung Medical's PE ratio of 13.91 is significantly lower than the industry average of 38.47 and the median of 41.87 [2] - The company ranks 34th in terms of PE ratio within its industry [1]

Group 1 - The high-pressure oxygen chamber concept sector rose by 1.57%, ranking 6th among concept sectors, with 9 stocks increasing in value [1] - Leading stocks in the high-pressure oxygen chamber sector included Tiebian Heavy Industry, Sanying Medical, and Weiao Co., which rose by 6.76%, 4.56%, and 2.41% respectively [1] - The sector experienced a net inflow of 0.17 billion yuan from main funds, with Tiebian Heavy Industry receiving the highest net inflow of 1.54 billion yuan [2][3] Group 2 - The main fund inflow ratios for Tiebian Heavy Industry, Aoyang Health, and Sanying Medical were 10.77%, 7.40%, and 4.90% respectively [3] - The trading turnover rates for the leading stocks in the high-pressure oxygen chamber sector were as follows: Tiebian Heavy Industry at 4.43%, Sanying Medical at 2.70%, and Aoyang Health at 7.82% [3] - Stocks that experienced declines included Jinling Pharmaceutical and International Medicine, which fell by 1.76% and 0.92% respectively [1][4]

Group 1 - As of August 5, 2025, Samsung Medical's stock price is 22.72 yuan, down 0.70% from the previous trading day, with an intraday fluctuation of 2.10% and a trading volume of 307 million yuan [1] - The company's main business includes smart power distribution equipment and medical services, with products such as electric meters, transformers, and charging piles, while also expanding into the medical rehabilitation industry [1] - The company is registered in Ningbo, Zhejiang, with a total market value of 31.927 billion yuan [1] Group 2 - From July to early August 2025, the company has been actively receiving research from multiple institutions, including Huaan Fund, Penghua Fund, and Jefferies, focusing on the global trend of increasing investment in power grids [1] - The research indicates a growing demand for smart power distribution equipment, particularly due to the construction of overseas data centers [1] - Over the past year, the company has received a total of 165 research visits from 116 institutions, with the most recent research leading to a stock price fluctuation of 3.74% over the following five trading days [1] Group 3 - On August 5, 2025, the net outflow of main funds was 16.302 million yuan, while the cumulative net inflow over the past five days was 118 million yuan [1]

证券日报网讯迦南智能（300880）8月5日在互动平台回答投资者提问时表示，公司目前暂无收购宁波三 星医疗（601567）电气股份有限公司的电力资产的相关计划或意向。 ...

三星医疗最新一期业绩显示，截至2025一季报，公司营业总收入36.31亿元、同比增长20.03%，归属净 利润4.89亿元，同比增长34.33%，扣非净利润4.60亿元，同比增长22.62%，流动比率1.804、速动比率 1.277、资产负债率47.79%。 天眼查商业履历信息显示，宁波三星医疗电气股份有限公司，成立于2007年，位于宁波市，是一家以从 事仪器仪表制造业为主的企业。企业注册资本141100.6571万人民币，实缴资本40050万人民币。公司法 定代表人为沈国英。 金融界消息 截至2025年8月1日收盘，三星医疗（601567）报收于22.67元，上涨0.8%，换手率2.15%， 成交量30.22万手，成交金额6.88亿元。 资金流向方面，今日主力资金净流入4599.40万元，占比成交额6.69%。其中，超大单净流入3033.94万 元、占成交额4.41%，大单净流入1565.46万元、占成交额2.28%，中单净流出流出1969.72万元、占成交 额2.86%，小单净流出2629.68万元、占成交额3.82%。 通过天眼查大数据分析，宁波三星医疗电气股份有限公司共对外投资了19家企业，参与招投标 ...

Market Overview - The grid equipment sector increased by 0.42% compared to the previous trading day, with Jinbei Electric leading the gains [1] - The Shanghai Composite Index closed at 3559.95, down 0.37%, while the Shenzhen Component Index closed at 10991.32, down 0.17% [1] Top Performers in Grid Equipment Sector - Jinbei Electric (002533) closed at 11.06, up 10.05%, with a trading volume of 988,500 shares and a transaction value of 1.073 billion [1] - Jinpan Technology (688676) closed at 40.51, up 6.89%, with a trading volume of 315,000 shares and a transaction value of 1.264 billion [1] - Other notable performers include ST Huicheng (002168) up 4.89%, Xidian New Energy (603312) up 4.85%, and Guoxin Technology (920037) up 4.58% [1] Underperformers in Grid Equipment Sector - Jinlihua Electric (300069) closed at 20.54, down 7.39%, with a trading volume of 164,000 shares and a transaction value of 350 million [2] - Liangxin Co. (002706) closed at 9.15, down 5.08%, with a trading volume of 864,200 shares and a transaction value of 805 million [2] - Other underperformers include Jinlongyu (002882) down 3.44% and Wenzhou Hongfeng (300283) down 3.15% [2] Capital Flow Analysis - The grid equipment sector experienced a net outflow of 36.5471 million from institutional investors, while retail investors saw a net inflow of 209 million [2] - Major stocks like Jinbei Electric had a net inflow of 207 million from institutional investors, but a net outflow of 109 million from speculative funds [3] - Other stocks such as Kelu Electronics (002121) and Shun Na Co. (000533) also showed mixed capital flows, with significant retail outflows [3]

融券方面，当日融券卖出0.03万股，净卖出0.02万股。 来源：金融界 7月31日，沪深两融数据显示，三星医疗获融资买入额0.68亿元，居两市第323位，当日融资偿还额0.90 亿元，净卖出2236.06万元。 最近三个交易日，29日-31日，三星医疗分别获融资买入0.52亿元、0.29亿元、0.68亿元。 ...

7月31日，三星医疗今日收盘22.49元，上涨4.31%，滚动市盈率PE（当前股价与前四季度每股收益总和 的比值）达到13.25倍，创13天以来新低，总市值316.04亿元。 最新一期业绩显示，2025年一季报，公司实现营业收入36.31亿元，同比20.03%；净利润4.89亿元，同 比34.33%，销售毛利率28.90%。 序号股票简称PE(TTM)PE(静)市净率总市值(元)5三星医疗13.2513.992.51316.04亿行业平均 36.1540.353.6793.67亿行业中值39.6442.402.7448.10亿1炬华科技11.1212.171.9680.88亿2新联电子 12.3018.011.4048.04亿3正泰电器12.3612.621.13488.89亿4金杯电工12.5212.971.8073.76亿6海兴电力 13.9912.981.79130.03亿7友讯达15.2113.582.5626.92亿8柘中股份17.1285.302.1862.39亿9长高电新 17.7718.041.8545.47亿10宏力达18.0416.780.9837.38亿11明阳电气18.1318.742 ...

Core Viewpoint - Samsung Medical's stock price increased by 4.31% to 22.49 yuan, with a trading volume of 522,452 hands and a transaction amount of 1.179 billion yuan as of July 31, 2025 [1] Company Overview - Samsung Medical operates in two main sectors: smart power distribution and medical services. The company is a leading manufacturer of smart meters and power information collection systems in China, with products exported to over 50 countries and regions worldwide [1] Recent Developments - The company's subsidiary in Mexico recently won a contract for the NexGrid smart meter framework project in the United States, valued at 29.55 million USD, approximately 212 million yuan. This project includes single-phase, two-phase, and three-phase smart meter products [1] - The company announced plans to cancel 5.7554 million shares held in the share repurchase special securities account, which will reduce the total share capital to 1.405 billion shares upon completion of the cancellation [1] Financial Insights - On July 31, the net inflow of main funds was 99.6421 million yuan, accounting for 0.32% of the circulating market value [1]

序号代码名称最新价涨跌幅主力净流入主力净占比1600588用友网络15.848.058.81亿元31.24%2002230科 大讯飞48.780.762.28亿元8.28%3002424贵州百灵5.9410.01.62亿元25.05%4000066中国长城15.080.531.48 亿元9.22%5601567三星医疗22.494.319964.21万元8.45%6300253卫宁健康10.870.747197.68万元 3.72%7300003乐普医疗15.560.846230.96万元5.49%8835207众诚科技30.165.684773.57万元 16.65%9300520科大国创24.941.634149.02万元8.25%10600839四川长虹9.860.23256.73万元3.47% 来源：金融界 7月31日，互联医疗概念上涨0.01%，今日主力资金流入3508.33万元，概念股38只上涨，55只下跌。 主力资金净流入居前的分别为用友网络（8.81亿元）、科大讯飞（2.28亿元）、贵州百灵（1.62亿 元）、中国长城（1.48亿元）、三星医疗（9964.21万元）。 ...